Influence of Lifestyle Modification in Renal Transplant Recipients With Postprandial Hyperglycemia
The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Abstract
INTRODUCTION: Lifestyle modification is recommended as first-line therapy to manage new-onset diabetes after transplantation (NODAT) and impaired glucose tolerance (IGT). No data currently demonstrate the efficacy of this approach specifically for transplant recipients. This study aimed to assess the benefit of intensive lifestyle modification in this high-risk group and to contrast this with the natural evolution of glucose metabolism after transplantation. METHODS: Baseline oral glucose tolerance test (OGTT) stratified 115 patients into two groups. Group 1 had glucose intolerance, IGT (n=28) and NODAT (n=8), and received intensive lifestyle modification (dietician referral, exercise program, weight loss advice). Group 2 had normal glucose tolerance (n=79) and received lifestyle modification leaflets. Both groups had follow-up OGTT after 6 months to assess change in glycemic status. RESULTS: Excluding all patients who received steroid weaning or withdrawal as part of their management, 111 patients were included in the analysis. Lifestyle modification in group 1 resulted in 15% improvement in 2-hr postprandial glucose versus 12% deterioration in group 2. In group 1, 44% (n=11) of IGT patients developed normal glucose tolerance, whereas only 4% (n=1) developed NODAT. Fifty-eight percent (n=4) of NODAT patients showed improvement (29% to IGT and 29% to normal). Glucose metabolism deteriorated in group 2 with 14% (n=10) developing IGT and 3% (n=2) developing NODAT. CONCLUSIONS: Glucose metabolism can deteriorate in transplant recipients despite passive lifestyle modification advice. This study shows active lifestyle modification benefits high-risk transplant recipients with glucose intolerance and should be aggressively pursued.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Presentation may range from mild hyperglycemia to frank DM, ranging from 1% to 6%.1606,1607”
From American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update. (2022) · cites this paper as [1606]
Citations
Cites
Tuomilehto, J., Lindström, J., Eriksson, J. G., Valle, T. T., Hämäläinen, H., Ilanne-Parikka, P., Keinänen-Kiukaanniemi, S., Laakso, M., Louheranta, A., Rastas, M., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200105033441801 · Cited by 10,873 · cited 1×
“(20) showed how the cumulative incidence of diabetes in a lifestyle intervention group was 11% compared with 23% in a TABLE 3.”
ResultPan, X.-R., Li, G.-W., Hu, Y.-H., Wang, J.-X., Yang, W.-Y., An, Z.-X., Hu, Z.-X., Juan-Lin, Xiao, J.-Z., Cao, H.-B., et al. (1997) · Diabetes Care · doi:10.2337/diacare.20.4.537 · Cited by 4,320
Boulé, N. G., Haddad, E., Kenny, G. P., Wells, G. A., & Sigal, R. J. (2001) · JAMA · doi:10.1001/jama.286.10.1218 · Cited by 1,889 · cited 2×
“(38) who conducted a meta-analysis of 14 controlled clinical trials assessing the effects of exercise on glycemic control and body mass in type 2 diabetics.”
BackgroundLindström, J., Ilanne-Parikka, P., Peltonen, M., Aunola, S., Eriksson, J. G., Hemiö, K., Hämäläinen, H., Härkönen, P., Keinänen-Kiukaanniemi, S., Laakso, M., et al. (2006) · The Lancet · doi:10.1016/s0140-6736(06)69701-8 · Cited by 1,799
(1999) · The Lancet · doi:10.1016/s0140-6736(98)12131-1 · Cited by 1,313
Borch‐Johnsen, K., Neil, A., Balkau, B., Larsen, S. H., Nissinen, A. E. T., Pekkanen, J., Keinanen-Kiukaanniemi, S. M., Hiltunen, L. A., Kivelä, S., Tuomilehto, J. O., et al. (1999) · The Lancet · Cited by 1,272
Tominaga, M., Eguchi, H., Manaka, H., Igarashi, K., Kato, T., & Sekikawa, A. (1999) · Diabetes Care · doi:10.2337/diacare.22.6.920 · Cited by 1,165
Writing committee, Unwin, N., Shaw, J., Zimmet, P., & Alberti, K. G. M. M. (2002) · Diabetic Medicine · doi:10.1046/j.1464-5491.2002.00835.x · Cited by 1,108 · cited 1×
“In the general population, studies have shown lifestyle modification can have beneficial effects on the diabetogenicity of an individual, especially in patients with IGT who are at high risk of developing diabetes (5, 10, 13, 16).”
BackgroundEtiology of Insulin Resistance
Petersen, K. F., & Shulman, G. I. (2006) · The American Journal of Medicine · doi:10.1016/j.amjmed.2006.01.009 · Cited by 825 · cited 2×
“Insulin resistance is a pathological state in which target cells fail to respond to ordinary levels of circulating insulin (35, 36).”
BackgroundPhysical Activity/Exercise and Type 2 Diabetes
Sigal, R. J., Kenny, G. P., Wasserman, D. H., & Castaneda-Sceppa, C. (2004) · Diabetes Care · doi:10.2337/diacare.27.10.2518 · Cited by 763 · cited 2×
“Suggested mechanisms include increased postreceptor insulin signaling, increased glucose transporter and messenger RNA and increased activity of glycogen synthase and hexokinase (39).”
Background
Research works printed but not linked: 1
- 2006, Standards of medical care in diabetes—2006., Diabetes Care, 29, S4
Cited by
Sharif, A., Hecking, M., de Vries, A. P. J., Porrini, E., Hornum, M., Rasoul-Rockenschaub, S., Berlakovich, G., Krebs, M., Kautzky-Willer, A., Schernthaner, G., et al. (2014) · American Journal of Transplantation · doi:10.1111/ajt.12850 · Cited by 532
“Sharif et al (46) demonstrated the potential for benefit from lifestyle modification in kidney allograft recipients with impaired glucose tolerance (13/25 patients reverted to normal glucose tolerance after median of 9 months, with only 1 progressing to PTDM).”
BackgroundSelf-citationExercise training for adults with chronic kidney disease
Heiwe, S., & Jacobson, S. H. (2011) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003236.pub2 · Cited by 481
Blonde, L., Umpierrez, G. E., Reddy, S. S., McGill, J. B., Berga, S. L., Bush, M., Chandrasekaran, S., DeFronzo, R. A., Einhorn, D., Galindo, R. J., et al. (2022) · Endocrine Practice · doi:10.1016/j.eprac.2022.08.002 · Cited by 507
Post-Transplant Diabetes Mellitus: Causes, Treatment, and Impact on Outcomes
Shivaswamy, V., Boerner, B., & Larsen, J. (2016) · Endocrine Reviews · doi:10.1210/er.2015-1084 · Cited by 328
Physical inactivity: a risk factor and target for intervention in renal care
Zelle, D. M., Klaassen, G., van Adrichem, E., Bakker, S. J. L., Corpeleijn, E., & Navis, G. (2017) · Nature Reviews Nephrology · doi:10.1038/nrneph.2016.187 · Cited by 282
Post-transplant diabetes mellitus in patients with solid organ transplants
Jenssen, T., & Hartmann, A. (2019) · Nature Reviews Endocrinology · doi:10.1038/s41574-018-0137-7 · Cited by 278
New-Onset Diabetes After Kidney Transplantation—Changes and Challenges
Yates, C. J., Fourlanos, S., Hjelmesæth, J., Colman, P. G., & Cohney, S. J. (2012) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2011.03855.x · Cited by 147
“Adoption of healthy dietary, exercise and weight control strategies has shown a 15% improvement in 2-h postprandial glucose over 6 months versus a 12% deterioration in controls (49).”
BackgroundLiefeldt, L., & Budde, K. (2010) · Transplant International · doi:10.1111/j.1432-2277.2010.01159.x · Cited by 153
“[118] demonstrated the benefits of aggressive lifestyle modification in attenuating abnormal glucose metabolism.”
BackgroundNovel views on new-onset diabetes after transplantation: development, prevention and treatment
Hecking, M., Werzowa, J., Haidinger, M., Horl, W. H., Pascual, J., Budde, K., Luan, F. L., Ojo, A., de Vries, A. P. J., Porrini, E., et al. (2013) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfs583 · Cited by 120
“Increased awareness of NODAT and the prediabetic states (impaired fasting glucose and impaired glucose tolerance, IGT) has fostered previous and present recommendations, based on the management of type 2 diabetes mellitus (T2DM).”
BackgroundInfluentialSelf-citationPhysical Activity in Kidney Transplant Recipients: A Review
Takahashi, A., Hu, S. L., & Bostom, A. G. (2018) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2017.12.005 · Cited by 119
New-onset diabetes mellitus after kidney transplantation: Current status and future directions
Palepu, S. (2015) · World Journal of Diabetes · doi:10.4239/wjd.v6.i3.445 · Cited by 119
Management of post‐transplant diabetes: immunosuppression, early prevention, and novel antidiabetics
Hecking, M., Sharif, A., Eller, K., & Jenssen, T. G. (2020) · Transplant International · doi:10.1111/tri.13783 · Cited by 125
“recipients was reported to facilitate reversal of impaired glucose tolerance to normal glucose tolerance within 6months in a nonrandomized study [90].”
BackgroundSelf-citationNew-onset diabetes mellitus after solid organ transplantation
Bodziak, K. A., & Hricik, D. E. (2008) · Transplant International · doi:10.1111/j.1432-2277.2008.00800.x · Cited by 116
“Sharif et al. recently demonstrated that aggressive lifestyle modification based on dietary changes, weight loss, and exercise reduced the incidence of NODAT in kidney transplant recipients with early laboratory signs of TAH [86].”
BackgroundInfluentialHaidinger, M., Werzowa, J., Hecking, M., Antlanger, M., Stemer, G., Pleiner, J., Kopecky, C., Kovarik, J. J., Döller, D., Pacini, G., et al. (2014) · American Journal of Transplantation · doi:10.1111/ajt.12518 · Cited by 110
“Additional studies are clearly required to explore the efficacy and feasibility of transplant-specific lifestyle intervention programs in patients with NODAT (56).”
BackgroundResultPost-Transplant Cardiovascular Disease
Birdwell, K. A., & Park, M. (2021) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.00520121 · Cited by 118
Post-transplantation diabetes—state of the art
Sharif, A., & Cohney, S. J. (2015) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(15)00387-3 · Cited by 99
Self-citationEmerging treatments for post-transplantation diabetes mellitus
Jenssen, T., & Hartmann, A. (2015) · Nature Reviews Nephrology · doi:10.1038/nrneph.2015.59 · Cited by 90
Post-Liver Transplantation Diabetes Mellitus: A Review of Relevance and Approach to Treatment
Peláez-Jaramillo, M. J., Cárdenas-Mojica, A. A., Gaete, P. V., & Mendivil, C. O. (2018) · Diabetes Therapy · doi:10.1007/s13300-018-0374-8 · Cited by 89
“Also in kidney transplant recipients, a 6-month intensive lifestyle modification program that included referral to a dietitian, a structured exercise program and weight loss advice induced regression to normoglycemia in up to 44% of IGT patients [120].”
BackgroundWerzowa, J., Hecking, M., Haidinger, M., Lechner, F., Döller, D., Pacini, G., Stemer, G., Pleiner, J., Frantal, S., & Säemann, M. D. (2013) · Transplantation · doi:10.1097/tp.0b013e318276a20e · Cited by 87
“Lifestyle interventions alone have already been shown to improve glycemic control in patients after kidney transplantation (31).”
BackgroundConte, C., & Secchi, A. (2018) · Acta Diabetologica · doi:10.1007/s00592-018-1137-8 · Cited by 81
Fong, J. N., & Moore, L. W. (2018) · Frontiers in Medicine · doi:10.3389/fmed.2018.00302 · Cited by 83
“In another trial comprised of two groups, Group 1 had insulin resistance or NODAT (n = 36) and received active lifestyle counseling, and Group 2 had normal glucose tolerance (n = 79) and only received leaflets on health behavior (65).”
BackgroundMetabolic Consequences of Solid Organ Transplantation
Bhat, M., Usmani, S. E., Azhie, A., & Woo, M. (2020) · Endocrine Reviews · doi:10.1210/endrev/bnaa030 · Cited by 80
Should Metformin Be Our Antiglycemic Agent of Choice Post-transplantation?
Sharif, A. (2011) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2011.03550.x · Cited by 69
“In addition, lifestyle modification has been shown to effectively treat NODAT and to attenuate the progression of prediabetes to NODAT in the transplant population (25).”
BackgroundSelf-citationReview: Metformin: Potential benefits and use in chronic kidney disease
PILMORE, H. L. (2010) · Nephrology · doi:10.1111/j.1440-1797.2010.01328.x · Cited by 69
Post-Transplantation Diabetes Mellitus
Ahmed, S. H., Biddle, K., Augustine, T., & Azmi, S. (2020) · Diabetes Therapy · doi:10.1007/s13300-020-00790-5 · Cited by 77
Wissing, K. M., Abramowicz, D., Weekers, L. E., Budde, K., Rath, T., Witzke, O., Broeders, N., Kianda, M. N., & Kuypers, D. R. J. (2018) · American Journal of Transplantation · doi:10.1111/ajt.14665 · Cited by 70
Post-transplant diabetes mellitus
Chowdhury, T. A. (2019) · Clinical Medicine · doi:10.7861/clinmed.2019-0195 · Cited by 71
New-Onset Diabetes After Kidney Transplantation: Prevalence, Risk Factors, and Management
Sarno, G., Muscogiuri, G., & Rosa, P. D. (2012) · Transplantation · doi:10.1097/tp.0b013e31824db97d · Cited by 64
“As already known, physical activity plays an important role in ameliorating glucose metabolism in obesity; in the same manner, regular exercise along with an appropriate nutrition therapy have shown to improve glucose metabolism and prevent the development of NODAT in kidney recipients who experienced hyperglycemia du…”
BackgroundKlaassen, G., Zelle, D. M., Navis, G. J., Dijkema, D., Bemelman, F. J., Bakker, S. J. L., & Corpeleijn, E. (2017) · BMC Nephrology · doi:10.1186/s12882-017-0709-0 · Cited by 61
“Dietary intervention after renal transplantation was shown to reduce body weight and improve lipid profile [20], whereas intensive lifestyle intervention improved glucose metabolism [21].”
BackgroundKesiraju, S., Paritala, P., Ch, U. M. R., & Sahariah, S. (2013) · Transplant Immunology · doi:10.1016/j.trim.2013.10.006 · Cited by 68
Pancreatic β-Cell Dysfunction and Risk of New-Onset Diabetes After Kidney Transplantation
Zelle, D. M., Corpeleijn, E., Deinum, J., Stolk, R. P., Gans, R. O. B., Navis, G., & Bakker, S. J. L. (2013) · Diabetes Care · doi:10.2337/dc12-1894 · Cited by 59
“(32) showed that lifestyle modification is beneficial for high-risk RTR with glucose intolerance.”
BackgroundInfluentialNew‐onset diabetes after renal transplantation
Tufton, N., Ahmad, S., Rolfe, C., Rajkariar, R., Byrne, C., & Chowdhury, T. A. (2014) · Diabetic Medicine · doi:10.1111/dme.12534 · Cited by 56
Glucocorticoids use in kidney transplant setting
de Lucena, D. D., & Rangel, É. B. (2018) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1080/17425255.2018.1530214 · Cited by 58
“Lifestyle modifications should be initially encouraged for both prevention and management of PTDM [132].”
Backgroundvon Düring, M. E., Jenssen, T. G., Bollerslev, J., Åsberg, A., Godang, K., & Hartmann, A. (2016) · Clinical Transplantation · doi:10.1111/ctr.12869 · Cited by 50
Kuningas, K., Driscoll, J., Mair, R., Smith, H. J., Dutton, M., Day, E., & Sharif, A. A. (2019) · Transplantation · doi:10.1097/tp.0000000000002969 · Cited by 49
“Previous work has shown the benefit of renal dietitian intervention to attenuate progression of abnormal glucose metabolism after kidney transplantation.(8) However, this was a nonrandomized study with dietitian intervention only offered to recipients with abnormal postprandial glucose metabolism.”
BackgroundSelf-citationNew-onset diabetes after transplantation: Risk factors and clinical impact
Räkel, A., & Karelis, A. D. (2011) · Diabetes & Metabolism · doi:10.1016/j.diabet.2010.09.003 · Cited by 52
“[137] showed that ifestyle modifications can benefit high-risk transplant recipints with glucose intolerance, and can attenuate and, in some m u w d”
BackgroundMetabolic risk profile in kidney transplant candidates and recipients
Piotti, G., Gandolfini, I., Palmisano, A., & Maggiore, U. (2018) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfy151 · Cited by 48
Macdonald, J. H., Kirkman, D. L., & Jibani, M. M. (2009) · Advances in Chronic Kidney Disease · doi:10.1053/j.ackd.2009.07.011 · Cited by 42
Langsford, D., & Dwyer, K. (2015) · World Journal of Diabetes · doi:10.4239/wjd.v6.i10.1132 · Cited by 44
Hyperglycemia and Diabetes Mellitus Following Organ Transplantation
Galindo, R. J., & Wallia, A. (2016) · Current Diabetes Reports · doi:10.1007/s11892-015-0707-1 · Cited by 39
Role of insulin resistance indices in predicting new-onset diabetes after kidney transplantation
Nagaraja, P., Ravindran, V. K., Morris‐Stiff, G. J., & Baboolal, K. (2012) · Transplant International · doi:10.1111/tri.12026 · Cited by 38
“However, these indices have been validated in dialysis patients and KTRs. Finally, homeostatic techniques such as HOMA may not accurately reflect the prevailing levels of insulin resistance and secretion.”
BackgroundInfluentialSelf-citationNew-onset diabetes after kidney transplant in children
Garro, R., Warshaw, B. L., & Felner, E. I. (2014) · Pediatric Nephrology · doi:10.1007/s00467-014-2830-7 · Cited by 39
“Intervention with diet control, exercise and weight loss in overweight patients should be initiated in the pre-transplant period to minimize and possibly eliminate modifiable risk factors for diabetes, including obesity and pre-transplant IGT [83].”
BackgroundKáposztás, Z., Gyürüs, É., & Kahan, B. D. (2011) · Transplantation Proceedings · doi:10.1016/j.transproceed.2011.04.008 · Cited by 33
“Modifiable risk factors need to be addressed first: Namely or obesity, an appropriate diet, weight loss, and exercise.(129) Meta-analyses support the efficacy of BS compared with nonsurgical therapy to achieve sustained weight loss among morbidly obese patients.”
BackgroundKanbay, M., Çöpür, S., Topçu, A. U., Güldan, M., Özbek, L., Gaipov, A., Ferro, C. J., Cozzolino, M. G., Cherney, D. Z. I., & Tuttle, K. R. (2024) · Diabetes Obesity and Metabolism · doi:10.1111/dom.15575 · Cited by 36
“114 A prospective cohort study showed that higher levels of moderate-to-vigorous physical activity were associated with a lower risk of PTDM (HR; 95% CI = 0.49; 0.25-0.96, p = .04), cardiovascular (0.34; 0.15-0.77, p = .01) and all-cause mortality (0.37; 0.24-0.58, p < .001) in renal transplant…”
BackgroundInfluentialA Narrative Review of Dietary Approaches for Kidney Transplant Patients
Cyrino, L. G., Galpern, J., Moore, L., Borgi, L., & Riella, L. V. (2021) · Kidney International Reports · doi:10.1016/j.ekir.2021.04.009 · Cited by 36
Glucose tolerance before and after renal transplantation
Bergrem, H. A., Valderhaug, T. G., Hartmann, A., Bergrem, H., Hjelmesaeth, J. S., & Jenssen, T. G. (2009) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfp566 · Cited by 32
“Since both diabetic [diabetes mellitus (DM)] and non-diabetic hyperglycaemia [impaired fasting glucose (IFG) or impaired glucose tolerance (IGT)] are amenable to intervention post-transplant [10], early identification of patients at risk of developing any form of post-transplant hyperglycaemia is of clinical importanc…”
Backgroundvon Düring, M. E., Jenssen, T. G., Bollerslev, J., Åsberg, A., Godang, K., Eide, I. A., Dahle, D. O., & Hartmann, A. (2015) · Transplant International · doi:10.1111/tri.12606 · Cited by 34
“Lifestyle prevention of PTDM has only been tested in one small intervention study with a modest improvement in postprandial glycaemia in the intervention group [19].”
BackgroundWilkinson, T. J., BISHOP, N. C., Billany, R. E., Lightfoot, C. J., Castle, E. M., Smith, A. C., & Greenwood, S. A. (2021) · Physical Therapy Reviews · doi:10.1080/10833196.2021.2002641 · Cited by 29
Prevention and management of new-onset diabetes mellitus in kidney transplantation.
Khong, M. J., & Chong, C. P. (2014) · PubMed · Cited by 29
Effects of Exercise and Sport in Solid Organ Transplant Recipients: A Review
Neale, J., Smith, A. C., & BISHOP, N. C. (2016) · American Journal of Physical Medicine & Rehabilitation · doi:10.1097/phm.0000000000000599 · Cited by 32
Górska, M., & Kurnatowska, I. (2022) · Nutrients · doi:10.3390/nu14234996 · Cited by 29
Hornum, M., Lindahl, J. P., von Zur‐Mühlen, B., Jenssen, T. G., & Feldt‐Rasmussen, B. (2013) · Transplant International · doi:10.1111/tri.12112 · Cited by 29
Early Post-Renal Transplant Hyperglycemia
Iqbal, A., Zhou, K., Kashyap, S. R., & Lansang, M. C. (2021) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgab697 · Cited by 31
Kiser, J. D., & Cantrell, G. K. (2006) · Supply chain management review · Cited by 41
Hyperglycemia management in patients with posttransplantation diabetes
Galindo, R. J., Fried, M., Breen, T., & Tamler, R. (2016) · Endocrine Practice · doi:10.4158/ep151039.ra · Cited by 25
Byambasukh, O., Osté, M. C. J., Neto, A. W. G., van den Berg, E., Navis, G. J., Bakker, S. J. L., & Corpeleijn, E. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9020415 · Cited by 25
“However, data on lifestyle interventions for improving glucose tolerance or observational data on the association of increased PA with incidences of PTDM are lacking [13,40].”
BackgroundRisk assessment and management of post-transplant diabetes mellitus
Han, E., Kim, M. S., Kim, Y. S., & Kang, E. S. (2016) · Metabolism · doi:10.1016/j.metabol.2016.07.011 · Cited by 30
Dynamics of Glucose Metabolism After Kidney Transplantation
Guthoff, M., Wagner, R. J., Weichbrodt, K., Nadalin, S., Königsrainer, A., Häring, H., Fritsche, A., & Heyne, N. (2017) · Kidney & Blood Pressure Research · doi:10.1159/000481375 · Cited by 24
Yeh, H., Lin, C., Li, Y., Yen, C., Lee, C., Chen, J., Chen, K., Tian, Y.-C., Liu, P., & Hsiao, C.-C. (2020) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-020-00541-3 · Cited by 24
de Lucena, D. D., de Sá, J. R., Pestana, J. O. M., & Rangel, É. B. (2020) · Journal of Diabetes Research · doi:10.1155/2020/1938703 · Cited by 22
Suarez, O., Pardo, M., Gonzalez, S., Escobar-Serna, D. P., Castañeda-Millán, D. A., Rodríguez, D., Osorio, J. C., & Lozano, E. (2014) · Transplantation Proceedings · doi:10.1016/j.transproceed.2014.07.011 · Cited by 21
“Taken together, early interventions such as a healthy diet, weight control, and regular exercise could negatively affect the incidence of NODAT [28]; lifestyle changes, such as those described by Sharf et al [42], should be implemented in the pre-transplantation care of these patients.”
BackgroundInsulin Resistance Indexes in Renal Transplant Recipients Maintained on Tacrolimus Immunosuppression
Sharif, A., Ravindran, V. K., Moore, R. H., Dunseath, G. J., Luzio, S. D., Owens, D. R., & Baboolal, K. (2010) · Transplantation · doi:10.1097/tp.0b013e3181bbf2c4 · Cited by 20
“The importance of these surrogates identifying insulin resistance, which is the principal cause of abnormal postprandial glycemia, lies in the ability of clinicians to initiate aggressive lifestyle modifications in response to rising indexes to attenuate or prevent impaired glucose tolerance and new onset diabetes aft…”
BackgroundSelf-citationPeracha, J., Nath, J., Ready, A. R., Tahir, S., Parekh, K., Hodson, J. A., Ferro, C. J., Borrows, R., & Sharif, A. (2016) · Transplant International · doi:10.1111/tri.12782 · Cited by 20
“Lifestyle modification should be advocated to all kidney allograft recipients based on potential benefit [27], but for South Asians likely needs tailoring to their unique cultural and dietary behaviour as they have a distinct cardio-metabolic risk profile compared with Caucasians [28].”
BackgroundSelf-citationSharif, A., Ravindran, V. K., Moore, R., Dunseath, G. J., Luzio, S. D., Owens, D. R., & Baboolal, K. (2009) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2009.02644.x · Cited by 19
“Immunosuppression modification aside, lifestyle modifications have been shown to lower postprandial glucose levels in transplant recipients with abnormal glucose metabolism (27).”
BackgroundSelf-citationLi, J., Chong, A., & Carey, S. (2021) · Nephrology · doi:10.1111/nep.13982 · Cited by 18
“In another study, aggressive lifestyle modifications including a dietitian referral, exercise program and weight loss advice improved postprandial glucose and glucose tolerance in patients with PTDM and impaired glucose tolerance.(19) Althoughmultiple dietary approaches may be effective in the prevention and managemen…”
BackgroundDiabetes in Kidney Transplantation
Cantarin, M. P. M. (2021) · Advances in Chronic Kidney Disease · doi:10.1053/j.ackd.2021.10.004 · Cited by 18
Management of the Hospitalized Transplant Patient
Boerner, B. P., Shivaswamy, V., Goldner, W. S., & Larsen, J. L. (2015) · Current Diabetes Reports · doi:10.1007/s11892-015-0585-6 · Cited by 18
Cheng, F., Li, Q., Wang, J., Wang, Z., Zeng, F., & Zhang, Y. (2022) · Saudi Pharmaceutical Journal · doi:10.1016/j.jsps.2022.05.013 · Cited by 15
“Lifestyle modifications (dietary advice, physical activity, and weight loss encouragement) in kidney transplant recipients has been reported to facilitate the reversal of impaired glucose tolerance to normal glucose tolerance within 6-months (Sharif et al., 2008).”
The Diagnosis of Posttransplantation Diabetes Mellitus: Meeting the Challenges
Werzowa, J. M., Hecking, M., Haidinger, M., Döller, D., Sharif, A., Tura, A., & Säemann, M. D. (2015) · Current Diabetes Reports · doi:10.1007/s11892-015-0601-x · Cited by 14
Self-citationTillmann, F.-P., Quack, I., Schenk, A. D., Grabensee, B., Rump, L. C., & Hetzel, G. R. (2012) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfs020 · Cited by 15
“Importantly, early intervention has been shown to be effective in renal transplant patients as well as in non-transplant populations [14].”
Risk and management of cardiac disease in kidney and liver transplant recipients
Shroff, G. R., Benjamin, M. M., Rangaswami, J., & Lentine, K. L. (2025) · Heart · doi:10.1136/heartjnl-2024-324796 · Cited by 15
“82 90 Impacts of immunosuppression on CVD, especially CHD and its risk factors, are an important consideration.”
Klangjareonchai, T., Eguchi, N., Tantisattamo, E., Ferrey, A., Reddy, U. G., Dafoe, D. C., & Ichii, H. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13030413 · Cited by 12
“Intensive modification of lifestyle including dietician referral, exercise programs, and weight loss advice can reverse glucose intolerance when compared to a passive approach [66].”
BackgroundNew-Onset Diabetes after Renal Transplantation
Mora, P. F. (2010) · Journal of Investigative Medicine · doi:10.2310/jim.0b013e3181e61a64 · Cited by 13
Du, Q., Li, T., Yi, X., Song, S., Kang, J. F., & Jiang, Y. (2024) · Acta Diabetologica · doi:10.1007/s00592-024-02253-w · Cited by 13
“A study revealed that lifestyle interventions implemented during the waiting period for organ transplantation can potentially mitigate the risk of PTDM [69].”
Review article: New‐onset diabetes after transplantation
Chow, K. M., & Li, P. K. (2008) · Nephrology · doi:10.1111/j.1440-1797.2008.01052.x · Cited by 12
“After intensive lifestyle modification in the former group, a 15% improvement in the 2 h postprandial tolerance was achieved, as compared to 12% deterioration in the conventional treatment group.(50) Although the evidence for lifestyle intervention in the general population is relatively KM Chow and PK-T Li 742”
BackgroundMethodClinical Trials for Treatment of NODAT
Sharif, A., de Vries, A. P. J., Porrini, E., Hecking, M., & Säemann, M. D. (2012) · Transplantation · doi:10.1097/tp.0b013e318260b1e9 · Cited by 10
Self-citationWilcox, J., Waite, C., Tomlinson, L., Driscoll, J., Karim, A., Day, E., & Sharif, A. (2016) · Trials · doi:10.1186/s13063-016-1543-6 · Cited by 11
Self-citationNovel management of diabetes in kidney transplantation
Ong, S., & Rhee, C. M. (2020) · Current Opinion in Nephrology & Hypertension · doi:10.1097/mnh.0000000000000665 · Cited by 10
“Tolerance diagnosed by OGTT with an intensive regimen consisting of dietician referral, an exercise program, and weight loss advice improved glucose control [33].”
Conte, C., Maggiore, U., Cappelli, G., Ietto, G., Lai, Q., Salis, P., Marchetti, P., Piemonti, L., Secchi, A., Capocasale, E., et al. (2020) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2020.05.004 · Cited by 10
Hecking, M., Sharif, A., Port, F. K., & Säemann, M. D. (2013) · Diabetes Care · doi:10.2337/dc13-1277 · Cited by 10
Self-citationExercise and Prediabetes After Renal Transplantation (EXPRED-I): A Prospective Study
Morales Febles, R., Marrero Miranda, D., Jiménez Sosa, A., González Rinne, A., Cruz Perera, C., Rodríguez-Rodríguez, A. E., Álvarez González, A., Díaz Martín, L., Negrín Mena, N., Acosta Sørensen, C., et al. (2023) · Sports Medicine - Open · doi:10.1186/s40798-023-00574-8 · Cited by 9
Renal posttransplantation diabetes mellitus: An overview
Pimentel, A. L., Bauer, A. C., & Camargo, J. L. (2015) · Clinica Chimica Acta · doi:10.1016/j.cca.2015.09.010 · Cited by 13
Is there a genetic predisposition to new-onset diabetes after kidney transplantation?
Reddy, Y. N. V., Abraham, G., Sundaram, V., Reddy, P., Mathew, M., Nagarajan, P., Mehra, N., Ramachandran, A., Ali, A. A. M., & Reddy, Y. N. V. (2015) · Saudi Journal of Kidney Diseases and Transplantation · doi:10.4103/1319-2442.168558 · Cited by 9
Cuomo, G., Cioffi, G., Lorenzo, A. D., Iannone, F. P., Cudemo, G., Iannicelli, A. M., Pacileo, M., D’Andrea, A., Vigorito, C., Iannuzzo, G., et al. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11113247 · Cited by 8
Castillo, R. F., Gallegos, R. F., de la Rosa, R. J. E., & Amaro, M. P. P. (2014) · PubMed · doi:10.3305/nh.2014.30.2.7584 · Cited by 8
Carbohydrate Metabolism in Kidney Disease and Kidney Failure
Ritz, E., Adamczak, M., & Więcek, A. (2012) · Elsevier eBooks · doi:10.1016/b978-0-12-391934-2.00002-3 · Cited by 10
Carbohydrate metabolism in chronic renal disease
Adamczak, M., Ritz, E., & Więcek, A. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-818540-7.00005-7 · Cited by 9
New onset of diabetes after transplant
Egan, L., & Sheejo, S. (2019) · Journal of Kidney Care · doi:10.12968/jokc.2019.4.4.180 · Cited by 7
Nagaraja, P., Sharif, A., Ravindran, V. K., & Baboolal, K. (2014) · Transplantation · doi:10.1097/01.tp.0000438202.11971.2e · Cited by 7
“In a study with 4 years of follow-up, Porrini et al. showed that KTRs with MS at 12 months posttransplant are more likely to develop NODAT compared to those without MS (log-rank 23.77, PG0.”
BackgroundInfluentialSelf-citationHap, K., Madziarska, K., Zmonarski, S. C., Kamińska, D., Magott-Procelewska, M., Banasik, M., Jędrzejak, K., Madziarski, M., Hap, W., Klinger, M., et al. (2018) · Transplantation Proceedings · doi:10.1016/j.transproceed.2018.03.125 · Cited by 7
Raven, L. M., Muir, C. A., Macdonald, P. S., Hayward, C., Jabbour, A., & Greenfield, J. R. (2022) · Acta Diabetologica · doi:10.1007/s00592-022-02018-3 · Cited by 6
Sharif, A., Ravindran, V. K., Dunseath, G. J., Luzio, S. D., Owens, D. R., & Baboolal, K. (2010) · Transplantation · doi:10.1097/tp.0b013e3181d9e1d8 · Cited by 6
“In a transplantation setting, we have previously shown how aggressive lifestyle modification (dietician referral, weight loss advice, and structured exercise program) can attenuate and even reverse abnormal postprandial glucose metabolism in renal transplant recipients with abnormal postprandial glucose tolerance (21).”
BackgroundSelf-citationDiagnosis and approach to posttransplant diabetes
Bonato, V., Cataldo, D., Dotta, F., & Carmellini, M. (2009) · Current Diabetes Reports · doi:10.1007/s11892-009-0049-y · Cited by 7
Graňák, K., Vnučák, M., Beliančinová, M., Kleinová, P., Blichová, T., Pytliaková, M., & Dedinská, I. (2024) · Medicina · doi:10.3390/medicina60081210 · Cited by 6
“…the fi rst intervention study in 2008, Sharif et al. pointed out that active lifestyle modi fi cation, including physical training, resulted in improved 2 h postprandial blood glucose levels in patients with already con fi rmed glucose intolerance [17]. with already confirmed glucose intolerance [17].”
BackgroundNew-Onset Posttransplant Diabetes Mellitus Begins in the Dialysis Period
Madziarska, K., & Klinger, M. (2011) · Journal of Renal Nutrition · doi:10.1053/j.jrn.2011.10.018 · Cited by 5
“Patients with impaired glucose tolerance who are on the waiting list should undergo an intensive lifestyle modification program (detailed diet and physical exercise instructions).(11) In this category of transplant candidates, the immunosuppressive regimen should balance the need for reduction of calcineurin inhibitor…”
Management of diabetes in people with advanced chronic kidney disease
Chowdhury, T. A., Mukuba, D., Casabar, M., Byrne, C., & Yaqoob, M. (2024) · Diabetic Medicine · doi:10.1111/dme.15402 · Cited by 6
Preventing and managing hyperglycemia in kidney transplant patients
Sharif, A. (2012) · Current Opinion in Nephrology & Hypertension · doi:10.1097/mnh.0b013e328358d5d0 · Cited by 5
“Aggressive lifestyle modification has been shown to improve glycemic control amongst kidney allograft recipients with established NODAT, with a 6-month intervention showing resolution of NODAT in four of seven recipients (two to impaired glucose tolerance, two to normal glucose tolerance) [20].”
BackgroundSelf-citationPosttransplantationsdiabetes mellitus: Eine Herausforderung für die Nachsorge
Albersmeyer, M., Gehr, B., Liebl, A., & Gerbig, D. (2020) · Der Nephrologe · doi:10.1007/s11560-020-00436-4 · Cited by 6
Grottenthaler, J. M., Füger, J. K., Mahling, M., Königsrainer, A., Malek, N. P., Birkenfeld, A. L., Nadalin, S., Berg, C. P., Heyne, N., & Guthoff, M. (2021) · Transplant International · doi:10.1111/tri.13967 · Cited by 5
“PTDM after kidney transplantation [45].”
Castle, E. M., McBride, E., Greenwood, J., Bramham, K., Chilcot, J., & Greenwood, S. A. (2021) · Kidney and Dialysis · doi:10.3390/kidneydial1020014 · Cited by 5
“Another study [47] reported a significant increase in the percentage of participants achieving two hours or more of PA per-week (28% vs.”
Background
Metadata
- Authors
- Sharif, A., Moore, R., & Baboolal, K.
- Affiliations
- University Hospital of Wales (GB)
- Corresponding author
- Sharif, Adnan
- Venue
- Transplantation
- Published
- 2008-02-15
- Volume
- 85
- Issue
- 3
- Pages
- 353-358
- ISSN
- 0041-1337 (ISSN-L)
- OpenAlex
- W1968567860
- Cited by
- 144
- References
- 39
- Citations by year
- 2026: 3 · 2025: 1 · 2024: 7 · 2023: 5 · 2022: 7 · 2021: 13 · 2020: 14 · 2019: 5 · 2018: 14 · 2017: 5 · 2016: 7 · 2015: 14 · 2014: 13 · 2013: 8 · 2012: 7
- FWCI
- 5.15
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Transplantation (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Transplantation › Renal Transplantation Outcomes and Treatments
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- lifestyle modification, kidney transplant recipients, postprandial hyperglycemia, post-transplant diabetes mellitus, impaired glucose tolerance, oral glucose tolerance test, exercise program, dietician referral, weight loss advice
- MeSH terms
- Female, Humans, Hyperglycemia, Life Style, Male, Middle Aged, Kidney Transplantation, Glucose Intolerance
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.